Tenderwize
Retour à la recherche

Open-house rebate agreement for Leuprorelin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 339 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Leuprorelin, ATC L02AE02

62/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

62 / 100

Complexité

58 / 100

Facteurs de risque

Submitting through the wrong portal area is explicitly prohibited; the notice says contract documents must be submitted...

The monthly cut-off is strict: complete and correct documents must be received by the 3rd for the next month’s start, a...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive open-house rebate agreements for Leuprorelin, ATC L02AE02.
  • Supply of pharmaceutical products under identical, non-individually negotiated contract terms.
Afficher le résumé complet

Open-house supply arrangement for pharmaceutical rebate agreements on Leuprorelin (ATC L02AE02) in Germany, led by AOK Bayern. The notice states that this is not a competitive procurement: all pharmaceutical companies meeting the stated suitability requirement can join on identical, non-negotiable terms. No contract value is stated. Submission is via DTVP or by paper originals, with monthly cut-off rules for contract start dates.

Risques

Submitting through the wrong portal area is explicitly prohibited; the notice says contract documents must be submitted...

The monthly cut-off is strict: complete and correct documents must be received by the 3rd for the next month’s start, a...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Only pharmaceutical companies may participate as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • The signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Leuprorelin

Open-house non-exclusive rebate agreement for the pharmaceutical product Leuprorelin (ATC L02AE02). Scope is supplies of pharmaceutical products. The lot information comes from structured data and the XML notice. Performance is in Germany, region DE212 (Bavaria/Munich area as buyer location, but place of performance is only given at country/subdivision level).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Sep 2025 - Sep 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Aug 03, 2027

Détails de la procédure

Date de publication
13 Aug 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
533423-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30